Related changes

Jump to: navigation, search

Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.

Recent changes options
Legend:
N
This edit created a new page (also see list of new pages)
m
This is a minor edit
b
This edit was performed by a bot
(±123)
The page size changed by this number of bytes
Show last 50 | 100 | 250 | 500 changes in last 1 | 3 | 7 | 14 | 30 days
Hide registered users | Hide anonymous users | Hide my edits | Show bots | Hide minor edits
Show new changes starting from 21:59, 15 September 2019
   
Page name:

15 September 2019

 m   21:56  Breast cancer‎‎ (2 changes | history) . . (+1,041). . [Jwarner‎ (2×)]
 m    21:56 (cur | prev) . . (+1,009). . Jwarner (talk | contribs) (Docetaxel & Gemcitabine {{#subobject:031a92|Regimen=1}})
 m    12:29 (cur | prev) . . (+32). . Jwarner (talk | contribs)
     21:14  Acute myeloid leukemia‎‎ (9 changes | history) . . (+4,052). . [Jwarner‎ (9×)]
 m    21:14 (cur | prev) . . (+731). . Jwarner (talk | contribs) (MEC {{#subobject:324735|Regimen=1}})
 m    16:10 (cur | prev) . . (+3). . Jwarner (talk | contribs)
 m    10:02 (cur | prev) . . (+746). . Jwarner (talk | contribs) (7+3i {{#subobject:717935|Regimen=1}})
 m    09:54 (cur | prev) . . (+3). . Jwarner (talk | contribs) (Variant #3, 100/13, CI Ara-C {{#subobject:7f2eec|Variant=1}})
 m    09:49 (cur | prev) . . (+3). . Jwarner (talk | contribs) (Variant #2, 100/12, CI Ara-C {{#subobject:c6cda|Variant=1}})
 m    09:34 (cur | prev) . . (+913). . Jwarner (talk | contribs) (7+3d & GO {{#subobject:869f84|Regimen=1}})
 m    09:32 (cur | prev) . . (+19). . Jwarner (talk | contribs) (Variant #1, CI Ara-C (100 mg/m2) {{#subobject:bb27bc|Variant=1}})
 m    09:29 (cur | prev) . . (+551). . Jwarner (talk | contribs) (References)
      09:28 (cur | prev) . . (+1,083). . Jwarner (talk | contribs) (HiDAC {{#subobject:1dddf5|Regimen=1}})
 m   17:12  Diffuse large B-cell lymphoma‎‎ (6 changes | history) . . (+1,013). . [Jwarner‎ (6×)]
 m    17:12 (cur | prev) . . (+5). . Jwarner (talk | contribs) (Regimen {{#subobject:60fc19|Variant=1}})
 m    16:58 (cur | prev) . . (+13). . Jwarner (talk | contribs) (Chemotherapy)
 m    16:57 (cur | prev) . . (+977). . Jwarner (talk | contribs)
 m    16:47 (cur | prev) . . (+10). . Jwarner (talk | contribs) (BR & Polatuzumab vedotin {{#subobject:1cc486|Regimen=1}})
 m    16:47 (cur | prev) . . (+3). . Jwarner (talk | contribs) (BR & Polatuzumab vedotin {{#subobject:1cc486|Regimen=1}})
 m    12:13 (cur | prev) . . (+5). . Jwarner (talk | contribs) (Regimen {{#subobject:e3e516|Variant=1}})
     17:04  Chronic lymphocytic leukemia‎ (diff | hist) . . (+1,545). . Jwarner (talk | contribs) (FCR {{#subobject:1dc12c|Regimen=1}})
     16:52  Follicular lymphoma‎‎ (4 changes | history) . . (+3,029). . [Jwarner‎ (4×)]
      16:52 (cur | prev) . . (+1,660). . Jwarner (talk | contribs)
 m    09:45 (cur | prev) . . (+3). . Jwarner (talk | contribs) (Variant #1 {{#subobject:f22c05|Variant=1}})
 m    09:45 (cur | prev) . . (+1,358). . Jwarner (talk | contribs) (Ibritumomab tiuxetan monotherapy {{#subobject:b0c8fb|Regimen=1}})
 m    09:39 (cur | prev) . . (+8). . Jwarner (talk | contribs) (Ibritumomab tiuxetan monotherapy {{#subobject:b0c8fb|Regimen=1}})
 m   16:44  Chronic myelogenous leukemia‎ (diff | hist) . . (+947). . Jwarner (talk | contribs) (Vincristine & Prednisone {{#subobject:7d31e7|Regimen=1}})
 m   16:40  Hairy cell leukemia‎ (diff | hist) . . (+5). . Jwarner (talk | contribs) (Regimen {{#subobject:3d2dea|Variant=1}})
 m   16:17  Neuroendocrine tumor‎ (diff | hist) . . (+3). . Jwarner (talk | contribs)
 m   16:07  Myelofibrosis‎ (diff | hist) . . (+3). . Jwarner (talk | contribs)
 m   13:01  Prostate cancer‎‎ (2 changes | history) . . (+937). . [Jwarner‎ (2×)]
 m    13:01 (cur | prev) . . (+3). . Jwarner (talk | contribs) (ADT & Darolutamide {{#subobject:d39ncb |Regimen=1}})
 m    10:15 (cur | prev) . . (+934). . Jwarner (talk | contribs) (Leuprolide monotherapy {{#subobject:12 |Regimen=1}})
 m   11:38  Renal cell carcinoma‎ (diff | hist) . . (+3). . Jwarner (talk | contribs)
 m   11:36  Cervical cancer‎ (diff | hist) . . (+5). . Jwarner (talk | contribs)
 m   11:36  Esophageal cancer‎‎ (2 changes | history) . . (+836). . [Jwarner‎ (2×)]
 m    11:36 (cur | prev) . . (+833). . Jwarner (talk | contribs)
 m    11:32 (cur | prev) . . (+3). . Jwarner (talk | contribs)
 m   11:31  Gastric cancer‎‎ (2 changes | history) . . (+8). . [Jwarner‎ (2×)]
 m    11:31 (cur | prev) . . (+5). . Jwarner (talk | contribs)
 m    10:26 (cur | prev) . . (+3). . Jwarner (talk | contribs)
 m   11:28  Bladder cancer‎ (diff | hist) . . (+8). . Jwarner (talk | contribs)
 m   11:27  Primary mediastinal B-cell lymphoma‎ (diff | hist) . . (+5). . Jwarner (talk | contribs)
 m   11:26  Hodgkin lymphoma‎ (diff | hist) . . (+5). . Jwarner (talk | contribs)
 m   11:26  Head and neck cancer‎ (diff | hist) . . (+8). . Jwarner (talk | contribs)
 m   11:25  Small cell lung cancer‎ (diff | hist) . . (+5). . Jwarner (talk | contribs)
 m   11:23  Non-small cell lung cancer‎‎ (5 changes | history) . . (+36). . [Jwarner‎ (5×)]
 m    11:23 (cur | prev) . . (+18). . Jwarner (talk | contribs)
 m    11:16 (cur | prev) . . (+3). . Jwarner (talk | contribs) (Variant #7, 120/30 {{#subobject:2bf191|Variant=1}})
 m    11:15 (cur | prev) . . (+3). . Jwarner (talk | contribs) (Variant #5, 100/25 {{#subobject:45998f|Variant=1}})
 m    10:23 (cur | prev) . . (+9). . Jwarner (talk | contribs)
 m    10:21 (cur | prev) . . (+3). . Jwarner (talk | contribs)
 m   11:21  Melanoma‎ (diff | hist) . . (+15). . Jwarner (talk | contribs)
 m   10:26  Colon cancer‎ (diff | hist) . . (+3). . Jwarner (talk | contribs)
 m   10:24  Mesothelioma‎ (diff | hist) . . (+3). . Jwarner (talk | contribs)
 m   10:20  Cutaneous T-cell lymphoma‎ (diff | hist) . . (+21). . Jwarner (talk | contribs) (PUVA)
     09:22  Pancreatic cancer‎‎ (2 changes | history) . . (+1,209). . [Jwarner‎ (2×)]
      09:22 (cur | prev) . . (+1,206). . Jwarner (talk | contribs) (Irinotecan liposomal monotherapy {{#subobject:9a99c8|Regimen=1}})
 m    09:15 (cur | prev) . . (+3). . Jwarner (talk | contribs) (Variant #2, 1000 mg/m2, 8-week lead-in ("Burris regimen") {{#subobject:5d6dd0|Variant=1}})